Metraipolis › archive › dc_6def799fa6ee

Considerations for Menstrual Suppression in Patients With Hematologic Malignancies — Europe PMC PMID:41660710

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41660710
DOI: 10.1002/phar.70114
License (as archived): solo-consultazione
Archived: 2026-11-05T11:17:57.533Z
SHA-256 of the archived text: 81671da6eb06dfb634fd683ffcfeab7b99293c0f398c98c61fedca2cc70b17e3
Stable URL of this page: https://metraipolis.com/documento/dc_6def799fa6ee

How to cite

Considerations for Menstrual Suppression in Patients With Hematologic Malignancies — Europe PMC PMID:41660710 — Europe PMC (en), https://europepmc.org/article/MED/41660710 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6def799fa6ee (Metraipolis archive dc_6def799fa6ee, sha256 81671da6eb06dfb634fd683ffcfeab7b99293c0f398c98c61fedca2cc70b17e3)

BibTeX

@misc{dc6def799fa6ee,
  title = {Considerations for Menstrual Suppression in Patients With Hematologic Malignancies — Europe PMC PMID:41660710},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41660710},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6def799fa6ee; sha256 81671da6eb06dfb634fd683ffcfeab7b99293c0f398c98c61fedca2cc70b17e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41660710. Agents can read the archived copy with the MCP tool read_document.